Dental AI Funding Map: Verified Rounds and What They Mean

Editorial correction (October 12, 2026): An earlier version stated or implied that Avized had a proprietary dataset or empirical results without supplying the underlying records. Those assertions have been withdrawn. This replacement distinguishes published research, vendor announcements, and illustrative planning models.

A sourced, selective funding timeline

The earlier edition described a complete funding landscape without providing announcement links for its rounds. That is not a defensible market-wide dataset. This replacement lists selected source-backed announcements, with explicit dates and financing definitions. It does not claim to capture every transaction or establish a total invested in dental AI.

March 5, 2024 — Overjet

Overjet announced $53.2 million in Series C financing. The round was led by March Capital. Other amounts and valuations reported in its announcement are vendor statements, and this was a 2024 event, not a Q3 2026 round.

July 24, 2024 — Pearl

Pearl announced $58 million in Series B financing, led by Left Lane Capital. This was announced in 2024, not a 2026 capital raise.

June 2025 — SuperDial

SuperDial announced $15 million in Series A-related financing. The announced amount included $3 million in venture debt. The round was announced in June 2025 and must not be recorded as Q3 2026 funding.

September 11, 2026 — Archy

Archy announced a $50 million Series C led by JMI Equity, with existing investors participating. This is an actual Q3 2026 funding announcement, rather than a product-spend commitment.

How to interpret funding in vendor selection

Funding can provide additional operating resources, but a press release is not proof of profitability, revenue retention, market share, or sufficient cash runway. Capital raised, venture debt, equity valuations, announced R&D commitments and merger consideration are different fields; they should not be added together as a single investment total.

When evaluating a vendor, request a verifiable timeline of capital events, product milestones, operational reliability, customer references, contractual commitments, and integration quality. Avoid using fundraising size as a proxy for product fit.

Rules for Avized's funding database

For each disclosed event, record company, event date, announcement date, round type, amount, currency, debt/equity split if given, investor names when publicly disclosed, source URL and observed date. Flag estimates separately. Do not sum amounts without applying a scope and deduplication method. If a source is unavailable, mark the event unverified rather than asserting a precise number.

Bottom line: these four selected rounds establish that capital has entered different parts of dental AI and practice software across different years. They do not, by themselves, describe the entire market.